These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 10323080

  • 1. Mutations of TP53, amplification of EGFR, MDM2 and CDK4, and deletions of CDKN2A in malignant astrocytomas.
    Biernat W, Debiec-Rychter M, Liberski PP.
    Pol J Pathol; 1998; 49(4):267-71. PubMed ID: 10323080
    [Abstract] [Full Text] [Related]

  • 2. Genetic profile of gliosarcomas.
    Reis RM, Könü-Lebleblicioglu D, Lopes JM, Kleihues P, Ohgaki H.
    Am J Pathol; 2000 Feb; 156(2):425-32. PubMed ID: 10666371
    [Abstract] [Full Text] [Related]

  • 3. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features.
    Benito R, Gil-Benso R, Quilis V, Perez M, Gregori-Romero M, Roldan P, Gonzalez-Darder J, Cerdá-Nicolas M, Lopez-Gines C.
    Neuropathology; 2010 Aug; 30(4):392-400. PubMed ID: 20051017
    [Abstract] [Full Text] [Related]

  • 4. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas.
    Skomedal H, Kristensen GB, Lie AK, Holm R.
    Gynecol Oncol; 1999 May; 73(2):223-8. PubMed ID: 10329038
    [Abstract] [Full Text] [Related]

  • 5. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T.
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [Abstract] [Full Text] [Related]

  • 6. p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma.
    Fulci G, Labuhn M, Maier D, Lachat Y, Hausmann O, Hegi ME, Janzer RC, Merlo A, Van Meir EG.
    Oncogene; 2000 Aug 03; 19(33):3816-22. PubMed ID: 10949938
    [Abstract] [Full Text] [Related]

  • 7. TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus.
    Skomedal H, Kristensen GB, Nesland JM, Børresen-Dale AL, Tropé C, Holm R.
    J Pathol; 1999 Apr 03; 187(5):556-62. PubMed ID: 10398121
    [Abstract] [Full Text] [Related]

  • 8. Deregulation of the p14ARF/Mdm2/p53 pathway and G1/S transition in two glioblastoma sets.
    Ghimenti C, Fiano V, Chiadò-Piat L, Chiò A, Cavalla P, Schiffer D.
    J Neurooncol; 2003 Jan 03; 61(2):95-102. PubMed ID: 12622447
    [Abstract] [Full Text] [Related]

  • 9. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.
    Reifenberger G, Ichimura K, Reifenberger J, Elkahloun AG, Meltzer PS, Collins VP.
    Cancer Res; 1996 Nov 15; 56(22):5141-5. PubMed ID: 8912848
    [Abstract] [Full Text] [Related]

  • 10. Molecular genetic analysis of giant cell glioblastomas.
    Meyer-Puttlitz B, Hayashi Y, Waha A, Rollbrocker B, Boström J, Wiestler OD, Louis DN, Reifenberger G, von Deimling A.
    Am J Pathol; 1997 Sep 15; 151(3):853-7. PubMed ID: 9284834
    [Abstract] [Full Text] [Related]

  • 11. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
    Burns KL, Ueki K, Jhung SL, Koh J, Louis DN.
    J Neuropathol Exp Neurol; 1998 Feb 15; 57(2):122-30. PubMed ID: 9600204
    [Abstract] [Full Text] [Related]

  • 12. A comparative study of epidermal growth factor receptor (EGFR) and MDM2 gene amplification and protein immunoreactivity in human glioblastomas.
    Rieske P, Kordek R, Bartkowiak J, Debiec-Rychter M, Biernat W, Liberski PP.
    Pol J Pathol; 1998 Feb 15; 49(3):145-9. PubMed ID: 9810172
    [Abstract] [Full Text] [Related]

  • 13. Primary and secondary glioblastomas: from concept to clinical diagnosis.
    Kleihues P, Ohgaki H.
    Neuro Oncol; 1999 Jan 15; 1(1):44-51. PubMed ID: 11550301
    [Abstract] [Full Text] [Related]

  • 14. Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase.
    Wiencke JK, Aldape K, McMillan A, Wiemels J, Moghadassi M, Miike R, Kelsey KT, Patoka J, Long J, Wrensch M.
    Cancer Epidemiol Biomarkers Prev; 2005 Jul 15; 14(7):1774-83. PubMed ID: 16030116
    [Abstract] [Full Text] [Related]

  • 15. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y, Tamiya T, Ichikawa T, Kunishio K, Matsumoto K, Furuta T, Ohmoto T, Ueki K, Louis DN.
    J Neuropathol Exp Neurol; 1996 Oct 15; 55(10):1026-31. PubMed ID: 8857999
    [Abstract] [Full Text] [Related]

  • 16. Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2A.
    Elnenaei MO, Gruszka-Westwood AM, A'Hernt R, Matutes E, Sirohi B, Powles R, Catovsky D.
    Haematologica; 2003 May 15; 88(5):529-37. PubMed ID: 12745272
    [Abstract] [Full Text] [Related]

  • 17. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
    Calogero A, Arcella A, De Gregorio G, Porcellini A, Mercola D, Liu C, Lombari V, Zani M, Giannini G, Gagliardi FM, Caruso R, Gulino A, Frati L, Ragona G.
    Clin Cancer Res; 2001 Sep 15; 7(9):2788-96. PubMed ID: 11555594
    [Abstract] [Full Text] [Related]

  • 18. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN.
    Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755
    [Abstract] [Full Text] [Related]

  • 19. Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme.
    Hayashi Y, Ueki K, Waha A, Wiestler OD, Louis DN, von Deimling A.
    Brain Pathol; 1997 Jul 01; 7(3):871-5. PubMed ID: 9217972
    [Abstract] [Full Text] [Related]

  • 20. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas.
    Kaulich K, Blaschke B, Nümann A, von Deimling A, Wiestler OD, Weber RG, Reifenberger G.
    J Neuropathol Exp Neurol; 2002 Dec 01; 61(12):1092-9. PubMed ID: 12484572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.